Aurinia (AUPH) investors got cold feet today, sending shares tumbling nearly 9%. The reason?
By Gene Munster Here are our five key takeaways following Netflix’s December results: Netflix reported Dec-18 revenue essentially in-line and earnings 25% above …
Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Lipocine (LPCN), …
What a wild ride it’s been for Kitov Pharma (KTOV). After skyrocketing nearly 170% in Tuesday’s trading session, shares of the pharmaceutical firm …
Some investors might love biotech stocks for their lottery ticket-like returns when a company strikes medical gold. A lottery ticket, however, costs only …
It’s a very rewarding trading day for investors in Microbot Medical (MBOT) with shares up over 20%, making the stock Wall Street’s bull …
Roku (ROKU) is expanding its reach. The streaming technology company announced it will allow users to subscribe to channels like Showtime, Starz and …
Shares of Amarin (AMRN), an Irish biopharma that markets a prescription fish oil medication called Vascepa, are on the move following the company’s …
Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Atossa Genetics …
The semiconductor industry is taking a hard hit as a global slowdown and increased supply of memory cause a ruckus in the marketplace. …
